Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Nancy Lee MD
Head and Neck [HN]
Head and Neck
To evaluate the safety and tolerability of bevacizumab (BV) plus chemoradiation
Data for this trial is being collected via the NRG/RTOG Data Center.
Confirmed histopathologic diagnosis of nasopharyngeal carcinoma: Types WHO I-IIb/III, Stage IIB-IVB; no head and neck surgery of the primary tumor or lymph nodes, except for incisional or excisional biopsies
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.